Wolverine Trading’s PAVmed PAVM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-32
Closed -$12.1K 4761
2022
Q3
$13K Sell
32
-15
-32% -$8.5K ﹤0.01% 4429
2022
Q2
$20K Buy
47
+16
+52% +$7.73K ﹤0.01% 4236
2022
Q1
$20K Sell
31
-32
-51% -$23.8K ﹤0.01% 5248
2021
Q4
$73K Sell
63
-34
-35% -$73.9K ﹤0.01% 5207
2021
Q3
$365K Buy
+97
New +$306K ﹤0.01% 4406
2021
Q2
Sell
-119
Closed -$281K 6513
2021
Q1
$249K Buy
+119
New +$179K ﹤0.01% 4725

Other funds holding PAVM

Wolverine Trading's PAVM Position: Q4 2022 in Review

Wolverine Trading sold out of PAVmed (PAVM) in Q4 2022, closing a stake of 32 shares — an estimated $12.1K sold.

Wolverine Trading first reported a position in PAVM in Q1 2021 and held it in 6 quarters. The position peaked at $365K in Q3 2021. 62 funds tracked by Wall St. Rank hold PAVM as of Q4 2022.

  • Wolverine Trading reported no remaining PAVmed position as of Q4 2022 after selling out during the quarter.
  • Wolverine Trading sold 32 PAVmed shares in Q4 2022, an estimated $12.1K.
  • Wolverine Trading first reported a position in PAVmed in Q1 2021 and held it in 6 quarters.
  • Wolverine Trading's PAVmed position peaked at $365K in Q3 2021.
  • 62 funds tracked by Wall St. Rank held PAVmed as of Q4 2022.

Based on Wolverine Trading's 13F filing for Q4 2022, filed 14 Feb 2023.